eyenovia-logo 3

Investor Relations

Investor Relations

Corporate Profile

Our Vision is to Improve Yours. Eyenovia is a public eye care company with topical ophthalmic therapies that are easier to use and easier to live with. The Optejet® is the only FDA-approved ophthalmic spray alternative to eye drops.

Presentation & Investor Materials

Minimum 15 minutes delayed. Source: LSEG

Recent News Releases
12/06/24
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering
11/25/24
Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering
11/22/24
Eyenovia Provides Update on Restructuring Efforts
Upcoming Events
There are currently no events scheduled.